SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Advik Lab - Quaterly Results

13 Oct 2021 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended September 2021, as compared to corresponding quarter of last year.The Net Loss for the quarter ended September 2021 is Rs. -0.12 millions as compared to Net Loss of Rs. -2.67 millions of corresponding quarter ended September 2020 Operating profit Margin for the quarter ended September 2021 improved to 0.99% as compared to -1.45% of corresponding quarter ended September 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.04 0.00
Other Income 2.54 0.09 2722.22 2.54 0.09 2722.22 1.95 0.11 1672.73
PBIDT 0.99 -1.45 -168.28 -0.68 -2.86 -76.22 -39.37 -6.63 493.82
Interest 0.01 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00
PBDT 0.98 -1.45 -167.59 -0.69 -2.86 -75.87 -39.38 -6.63 493.97
Depreciation 1.28 1.42 -9.86 2.56 2.84 -9.86 5.56 5.73 -2.97
PBT -0.30 -2.87 -89.55 -3.25 -5.70 -42.98 -44.94 -12.36 263.59
TAX -0.18 -0.20 -10.00 -0.34 -0.40 -15.00 -0.78 -0.70 11.43
Deferred Tax -0.18 -0.20 -10.00 -0.34 -0.40 -15.00 -0.78 -0.70 11.43
PAT -0.12 -2.67 -95.51 -2.91 -5.30 -45.09 -44.16 -11.66 278.73
Equity 191.11 191.11 0.00 191.11 191.11 0.00 191.11 191.11 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -16575.00 0.00

MPS Pharmaa Share Price

1.73 0.00 (0.00%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1672.10
Dr. Reddys Lab 1238.50
Cipla 1237.90
Zydus Lifesciences 942.00
Lupin 2334.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×